Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax
Catalpol, an iridoid glucoside found in the root of Rehmannia glutinosa Libosch, has been demonstrated to reduce apoptosis in neuronal cell lines. Recent data suggests that catalpol also exerts anti-apoptotic effects on other cell types. The aim of the present study was to investigate whether catalp...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2010-02, Vol.628 (1), p.155-163 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 163 |
---|---|
container_issue | 1 |
container_start_page | 155 |
container_title | European journal of pharmacology |
container_volume | 628 |
creator | Hu, Lingai Sun, Yukun Hu, Jian |
description | Catalpol, an iridoid glucoside found in the root of
Rehmannia glutinosa Libosch, has been demonstrated to reduce apoptosis in neuronal cell lines. Recent data suggests that catalpol also exerts anti-apoptotic effects on other cell types. The aim of the present study was to investigate whether catalpol protects against hydrogen peroxide (H
2O
2) induced apoptosis in human umbilical vein endothelial cells (HUVECs). Apoptotic cells were detected by terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling, Annexin V-fluorescein isothiocyanate binding assay and by assessment of caspase-3 activity. The level of intracellular reactive oxygen species was quantified by 2′, 7′-dichlorofluorescein diacetate assay. Expression of Akt, Bad, Bcl-2 and Bax mRNA and protein was determined by real-time semiquantitative reverse transcription-polymerase chain reaction and Western blotting. Apoptosis in HUVECs was associated with increased Bax, decreased Bcl-2 activity and inactivated phosphorylation of Akt and Bad after 24
h of H
2O
2 exposure. Pre-treatment of HUVECs with catalpol significantly reduced H
2O
2-induced intracellular reactive oxygen species release. Catalpol not only increased the expression of Bcl-2, while decreasing Bax expression, but also induced Akt activation and Bad phosphorylation, and ultimately reduced H
2O
2-induced apoptosis. The protective effects of catalpol were partially inhibited by the phosphatidylinositol 3-kinase (PI3K) antagonist wortmannin or 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Taken together, these results suggest that pre-treatment of HUVECs with catalpol can block H
2O
2-induced apoptosis, and that the underlying mechanism involves reactive oxygen species scavenging, activation of the PI3K/Akt–Bad signaling pathway and increased Bcl-2 and decreased Bax expression. |
doi_str_mv | 10.1016/j.ejphar.2009.11.046 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733850853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S001429990901098X</els_id><sourcerecordid>733850853</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-43badf3ece32369125172210cc92f1300f17ce26b03fffe834253e9ef00418043</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEotPCGyDkDWKV1JfcvEFqRxQqKsEC1pbjHE88JHawnTLzLjwsHjKCHasj_frORefLslcEFwST-npfwH4epC8oxrwgpMBl_STbkLbhOW4IfZptMCZlTjnnF9llCHuMccVp9Ty7IJzXlDf1Jvu1lVGOsxuRsYPpTAxIzm6OLpiQIjQce-92YNEM3h1MD7mx_aKgR2B7FwcYzTKh7oikiuZRRmN3KKXoyz37dH3zPaJgdlaOp3iWcfgpE2l7NLl-GVcaDrOHEIyzyGl0q8ac_kFu5eFF9kzLMcDLc73Kvt29_7r9mD98_nC_vXnIVVk1MS9ZJ3vNQAGjrOaEVqShlGClONWEYaxJo4DWHWZaa2hZSSsGHDTGJWlxya6yt-vc2bsfC4QoJhMUjKO04JYgGsbaCrcVS2S5ksq7EDxoMXszSX8UBIuTFrEXqxZx0iIIEUlLant9XrB0E_T_ms4eEvDmDMig5Ki9tMqEvxylZZM8Nol7t3KQ3vFowIugDNjkw3hQUfTO_P-S35_nr0Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733850853</pqid></control><display><type>article</type><title>Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Hu, Lingai ; Sun, Yukun ; Hu, Jian</creator><creatorcontrib>Hu, Lingai ; Sun, Yukun ; Hu, Jian</creatorcontrib><description>Catalpol, an iridoid glucoside found in the root of
Rehmannia glutinosa Libosch, has been demonstrated to reduce apoptosis in neuronal cell lines. Recent data suggests that catalpol also exerts anti-apoptotic effects on other cell types. The aim of the present study was to investigate whether catalpol protects against hydrogen peroxide (H
2O
2) induced apoptosis in human umbilical vein endothelial cells (HUVECs). Apoptotic cells were detected by terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling, Annexin V-fluorescein isothiocyanate binding assay and by assessment of caspase-3 activity. The level of intracellular reactive oxygen species was quantified by 2′, 7′-dichlorofluorescein diacetate assay. Expression of Akt, Bad, Bcl-2 and Bax mRNA and protein was determined by real-time semiquantitative reverse transcription-polymerase chain reaction and Western blotting. Apoptosis in HUVECs was associated with increased Bax, decreased Bcl-2 activity and inactivated phosphorylation of Akt and Bad after 24
h of H
2O
2 exposure. Pre-treatment of HUVECs with catalpol significantly reduced H
2O
2-induced intracellular reactive oxygen species release. Catalpol not only increased the expression of Bcl-2, while decreasing Bax expression, but also induced Akt activation and Bad phosphorylation, and ultimately reduced H
2O
2-induced apoptosis. The protective effects of catalpol were partially inhibited by the phosphatidylinositol 3-kinase (PI3K) antagonist wortmannin or 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Taken together, these results suggest that pre-treatment of HUVECs with catalpol can block H
2O
2-induced apoptosis, and that the underlying mechanism involves reactive oxygen species scavenging, activation of the PI3K/Akt–Bad signaling pathway and increased Bcl-2 and decreased Bax expression.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2009.11.046</identifier><identifier>PMID: 19962976</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Animals ; Apoptosis ; Apoptosis - drug effects ; bcl-2-Associated X Protein - metabolism ; Biological and medical sciences ; Catalpol ; Cell Survival - drug effects ; Endothelial Cells - cytology ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Endothelium, Vascular - cytology ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - metabolism ; Free Radical Scavengers - pharmacology ; Gene Expression Regulation - drug effects ; Humans ; HUVEC ; Hydrogen peroxide ; Hydrogen Peroxide - pharmacology ; Medical sciences ; Pharmacology. Drug treatments ; Phosphatidylinositol 3-Kinases - metabolism ; Phosphorylation - drug effects ; Proto-Oncogene Proteins c-akt - metabolism ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Quaternary Ammonium Compounds - pharmacology ; Reactive Oxygen Species - metabolism ; Signal Transduction - drug effects ; Umbilical Veins - cytology</subject><ispartof>European journal of pharmacology, 2010-02, Vol.628 (1), p.155-163</ispartof><rights>2009 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-43badf3ece32369125172210cc92f1300f17ce26b03fffe834253e9ef00418043</citedby><cites>FETCH-LOGICAL-c457t-43badf3ece32369125172210cc92f1300f17ce26b03fffe834253e9ef00418043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S001429990901098X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22472997$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19962976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hu, Lingai</creatorcontrib><creatorcontrib>Sun, Yukun</creatorcontrib><creatorcontrib>Hu, Jian</creatorcontrib><title>Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Catalpol, an iridoid glucoside found in the root of
Rehmannia glutinosa Libosch, has been demonstrated to reduce apoptosis in neuronal cell lines. Recent data suggests that catalpol also exerts anti-apoptotic effects on other cell types. The aim of the present study was to investigate whether catalpol protects against hydrogen peroxide (H
2O
2) induced apoptosis in human umbilical vein endothelial cells (HUVECs). Apoptotic cells were detected by terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling, Annexin V-fluorescein isothiocyanate binding assay and by assessment of caspase-3 activity. The level of intracellular reactive oxygen species was quantified by 2′, 7′-dichlorofluorescein diacetate assay. Expression of Akt, Bad, Bcl-2 and Bax mRNA and protein was determined by real-time semiquantitative reverse transcription-polymerase chain reaction and Western blotting. Apoptosis in HUVECs was associated with increased Bax, decreased Bcl-2 activity and inactivated phosphorylation of Akt and Bad after 24
h of H
2O
2 exposure. Pre-treatment of HUVECs with catalpol significantly reduced H
2O
2-induced intracellular reactive oxygen species release. Catalpol not only increased the expression of Bcl-2, while decreasing Bax expression, but also induced Akt activation and Bad phosphorylation, and ultimately reduced H
2O
2-induced apoptosis. The protective effects of catalpol were partially inhibited by the phosphatidylinositol 3-kinase (PI3K) antagonist wortmannin or 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Taken together, these results suggest that pre-treatment of HUVECs with catalpol can block H
2O
2-induced apoptosis, and that the underlying mechanism involves reactive oxygen species scavenging, activation of the PI3K/Akt–Bad signaling pathway and increased Bcl-2 and decreased Bax expression.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>bcl-2-Associated X Protein - metabolism</subject><subject>Biological and medical sciences</subject><subject>Catalpol</subject><subject>Cell Survival - drug effects</subject><subject>Endothelial Cells - cytology</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelium, Vascular - cytology</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - metabolism</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>HUVEC</subject><subject>Hydrogen peroxide</subject><subject>Hydrogen Peroxide - pharmacology</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Phosphorylation - drug effects</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Quaternary Ammonium Compounds - pharmacology</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Umbilical Veins - cytology</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu1DAUhiMEotPCGyDkDWKV1JfcvEFqRxQqKsEC1pbjHE88JHawnTLzLjwsHjKCHasj_frORefLslcEFwST-npfwH4epC8oxrwgpMBl_STbkLbhOW4IfZptMCZlTjnnF9llCHuMccVp9Ty7IJzXlDf1Jvu1lVGOsxuRsYPpTAxIzm6OLpiQIjQce-92YNEM3h1MD7mx_aKgR2B7FwcYzTKh7oikiuZRRmN3KKXoyz37dH3zPaJgdlaOp3iWcfgpE2l7NLl-GVcaDrOHEIyzyGl0q8ac_kFu5eFF9kzLMcDLc73Kvt29_7r9mD98_nC_vXnIVVk1MS9ZJ3vNQAGjrOaEVqShlGClONWEYaxJo4DWHWZaa2hZSSsGHDTGJWlxya6yt-vc2bsfC4QoJhMUjKO04JYgGsbaCrcVS2S5ksq7EDxoMXszSX8UBIuTFrEXqxZx0iIIEUlLant9XrB0E_T_ms4eEvDmDMig5Ki9tMqEvxylZZM8Nol7t3KQ3vFowIugDNjkw3hQUfTO_P-S35_nr0Y</recordid><startdate>20100225</startdate><enddate>20100225</enddate><creator>Hu, Lingai</creator><creator>Sun, Yukun</creator><creator>Hu, Jian</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100225</creationdate><title>Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax</title><author>Hu, Lingai ; Sun, Yukun ; Hu, Jian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-43badf3ece32369125172210cc92f1300f17ce26b03fffe834253e9ef00418043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>bcl-2-Associated X Protein - metabolism</topic><topic>Biological and medical sciences</topic><topic>Catalpol</topic><topic>Cell Survival - drug effects</topic><topic>Endothelial Cells - cytology</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelium, Vascular - cytology</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - metabolism</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>HUVEC</topic><topic>Hydrogen peroxide</topic><topic>Hydrogen Peroxide - pharmacology</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Phosphorylation - drug effects</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Quaternary Ammonium Compounds - pharmacology</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Umbilical Veins - cytology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hu, Lingai</creatorcontrib><creatorcontrib>Sun, Yukun</creatorcontrib><creatorcontrib>Hu, Jian</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hu, Lingai</au><au>Sun, Yukun</au><au>Hu, Jian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2010-02-25</date><risdate>2010</risdate><volume>628</volume><issue>1</issue><spage>155</spage><epage>163</epage><pages>155-163</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>Catalpol, an iridoid glucoside found in the root of
Rehmannia glutinosa Libosch, has been demonstrated to reduce apoptosis in neuronal cell lines. Recent data suggests that catalpol also exerts anti-apoptotic effects on other cell types. The aim of the present study was to investigate whether catalpol protects against hydrogen peroxide (H
2O
2) induced apoptosis in human umbilical vein endothelial cells (HUVECs). Apoptotic cells were detected by terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling, Annexin V-fluorescein isothiocyanate binding assay and by assessment of caspase-3 activity. The level of intracellular reactive oxygen species was quantified by 2′, 7′-dichlorofluorescein diacetate assay. Expression of Akt, Bad, Bcl-2 and Bax mRNA and protein was determined by real-time semiquantitative reverse transcription-polymerase chain reaction and Western blotting. Apoptosis in HUVECs was associated with increased Bax, decreased Bcl-2 activity and inactivated phosphorylation of Akt and Bad after 24
h of H
2O
2 exposure. Pre-treatment of HUVECs with catalpol significantly reduced H
2O
2-induced intracellular reactive oxygen species release. Catalpol not only increased the expression of Bcl-2, while decreasing Bax expression, but also induced Akt activation and Bad phosphorylation, and ultimately reduced H
2O
2-induced apoptosis. The protective effects of catalpol were partially inhibited by the phosphatidylinositol 3-kinase (PI3K) antagonist wortmannin or 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Taken together, these results suggest that pre-treatment of HUVECs with catalpol can block H
2O
2-induced apoptosis, and that the underlying mechanism involves reactive oxygen species scavenging, activation of the PI3K/Akt–Bad signaling pathway and increased Bcl-2 and decreased Bax expression.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>19962976</pmid><doi>10.1016/j.ejphar.2009.11.046</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2010-02, Vol.628 (1), p.155-163 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_733850853 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Animals Apoptosis Apoptosis - drug effects bcl-2-Associated X Protein - metabolism Biological and medical sciences Catalpol Cell Survival - drug effects Endothelial Cells - cytology Endothelial Cells - drug effects Endothelial Cells - metabolism Endothelium, Vascular - cytology Endothelium, Vascular - drug effects Endothelium, Vascular - metabolism Free Radical Scavengers - pharmacology Gene Expression Regulation - drug effects Humans HUVEC Hydrogen peroxide Hydrogen Peroxide - pharmacology Medical sciences Pharmacology. Drug treatments Phosphatidylinositol 3-Kinases - metabolism Phosphorylation - drug effects Proto-Oncogene Proteins c-akt - metabolism Proto-Oncogene Proteins c-bcl-2 - metabolism Quaternary Ammonium Compounds - pharmacology Reactive Oxygen Species - metabolism Signal Transduction - drug effects Umbilical Veins - cytology |
title | Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T23%3A20%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Catalpol%20inhibits%20apoptosis%20in%20hydrogen%20peroxide-induced%20endothelium%20by%20activating%20the%20PI3K/Akt%20signaling%20pathway%20and%20modulating%20expression%20of%20Bcl-2%20and%20Bax&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Hu,%20Lingai&rft.date=2010-02-25&rft.volume=628&rft.issue=1&rft.spage=155&rft.epage=163&rft.pages=155-163&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/j.ejphar.2009.11.046&rft_dat=%3Cproquest_cross%3E733850853%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733850853&rft_id=info:pmid/19962976&rft_els_id=S001429990901098X&rfr_iscdi=true |